Presentation TCT 2013 TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus Presenter: Elvin Kedhi October 29, 2013
Presentation TCT 2013 TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study Presenter: Thomas Stuckey October 29, 2013
Presentation TCT 2013 An Overview of Patient Risk Stratification in Patients Enrolled in the CoreValve US Extreme Risk Study Presenter: Thomas Gleason October 29, 2013
Presentation TCT 2013 TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study... Presenter: Colin Berry October 29, 2013
Presentation TCT 2013 TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery Presenter: Gerhard Schymik October 29, 2013
Presentation TCT 2013 Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices Presenter: Koen Keirse October 29, 2013
Presentation Efficient Evaluation for TAVR: What Do We Really Need? Presenter: John Webb October 29, 2013
Presentation TCT 2013 Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety Presenter: Lian R. Gao October 29, 2013
Presentation TCT 2013 SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary... Presenter: Bent Raungaard October 29, 2013
Presentation TCT 2013 Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA) Presenter: Julie Logan October 29, 2013